Rani Therapeutics Holdings, Inc. (RANI)Healthcare | Biotechnology | San Jose, United States | NasdaqGM
0.98 USD
+0.06
(6.982%)
⇧
(April 17, 2026, 1:06 p.m.
EDT)
Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 2:48 p.m. EDT
RANI is a highly volatile stock with a significant short interest and weak fundamentals, including negative earnings and a low price-to-book ratio. The recent price action shows a downtrend, and the options activity suggests a bearish outlook. While there is some support at the $0.5 strike, the overall picture is not favorable for short-term traders. Long-term investors should be cautious, as the company's fundamentals are not strong, and there is no dividend history. The stock is more suitable for speculative trading rather than long-term investment. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.123511 |
| MSTL | 0.193410 |
| AutoETS | 0.194610 |
| AutoARIMA | 0.200718 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 50% |
| H-stat | 4.00 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.257 |
| Excess Kurtosis | -0.89 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 10.402 |
| Revenue per Share | 0.025 |
| Market Cap | 97,976,792 |
| Forward P/E | -4.31 |
| Beta | 0.66 |
| Website | https://www.ranitherapeutics.com |
As of April 11, 2026, 2:48 p.m. EDT: Options speculators are showing a mixed sentiment. The calls show a concentration of open interest (OI) on the downside, with significant OI on the put side, especially around the $0.5 strike. This indicates a bearish bias, as puts are being heavily positioned, suggesting potential downside risk. However, there are some signs of support at the $0.5 strike, which could act as a floor. The IV is low, which may indicate a lack of volatility expectations, but the high OI on puts suggests some traders are preparing for a decline. The overall options activity implies caution, with more emphasis on downside protection rather than upside potential.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.15688074 |
| Address1 | 2,051 Ringwood Avenue |
| All Time High | 36.27 |
| All Time Low | 0.387 |
| Ask | 1.15 |
| Ask Size | 2 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 1,009,780 |
| Average Daily Volume3 Month | 1,113,127 |
| Average Volume | 1,113,127 |
| Average Volume10Days | 1,009,780 |
| Beta | 0.661 |
| Bid | 0.9617 |
| Bid Size | 1 |
| Book Value | 0.338 |
| City | San Jose |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.9825 |
| Current Ratio | 4.209 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.99 |
| Day Low | 0.8819 |
| Debt To Equity | 10.402 |
| Display Name | Rani Therapeutics |
| Earnings Call Timestamp End | 1,774,557,000 |
| Earnings Call Timestamp Start | 1,774,557,000 |
| Earnings Timestamp | 1,774,555,200 |
| Earnings Timestamp End | 1,778,702,400 |
| Earnings Timestamp Start | 1,778,702,400 |
| Ebitda | -37,410,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -1.464 |
| Enterprise To Revenue | 33.531 |
| Enterprise Value | 54,755,452 |
| Eps Current Year | -0.194 |
| Eps Forward | -0.228 |
| Eps Trailing Twelve Months | -0.45 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.14374 |
| Fifty Day Average Change | -0.16124004 |
| Fifty Day Average Change Percent | -0.14097613 |
| Fifty Two Week Change Percent | -15.688074 |
| Fifty Two Week High | 3.87 |
| Fifty Two Week High Change | -2.8874998 |
| Fifty Two Week High Change Percent | -0.746124 |
| Fifty Two Week Low | 0.387 |
| Fifty Two Week Low Change | 0.5955 |
| Fifty Two Week Low Change Percent | 1.5387597 |
| Fifty Two Week Range | 0.387 - 3.87 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,627,651,800,000 |
| Float Shares | 64,320,643 |
| Forward Eps | -0.228 |
| Forward P E | -4.309211 |
| Free Cashflow | -6,789,625 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 69 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 1,633,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.05609 |
| Held Percent Institutions | 0.49617 |
| Implied Shares Outstanding | 99,721,927 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-07-30 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; RT-116 which is in discovery stage for the treatment of obesity; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The has a collaboration agreement with ProGen Co., Ltd. for the o-development and commercialization of RT-114 to treat obesity. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California. |
| Long Name | Rani Therapeutics Holdings, Inc. |
| Market | us_market |
| Market Cap | 97,976,792 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_242425883 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -29,673,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 90,996,258 |
| Number Of Analyst Opinions | 5 |
| Open | 0.92 |
| Operating Cashflow | -18,714,000 |
| Operating Margins | -5.8418903 |
| Payout Ratio | 0.0 |
| Phone | 408 457 3700 |
| Previous Close | 0.919 |
| Price Eps Current Year | -5.064433 |
| Price Hint | 4 |
| Price To Book | 2.9068048 |
| Price To Sales Trailing12 Months | 59.998035 |
| Profit Margins | 0.0 |
| Quick Ratio | 4.085 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.25 |
| Region | US |
| Regular Market Change | 0.06349999 |
| Regular Market Change Percent | 6.9818563 |
| Regular Market Day High | 0.99 |
| Regular Market Day Low | 0.8819 |
| Regular Market Day Range | 0.8819 - 0.99 |
| Regular Market Open | 0.92 |
| Regular Market Previous Close | 0.919 |
| Regular Market Price | 0.9825 |
| Regular Market Time | 1,776,445,592 |
| Regular Market Volume | 1,035,598 |
| Return On Assets | -0.50273 |
| Return On Equity | -1.8197999 |
| Revenue Growth | 0.421 |
| Revenue Per Share | 0.025 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 99,721,927 |
| Shares Percent Shares Out | 0.1014 |
| Shares Short | 10,113,183 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 11,539,340 |
| Short Name | Rani Therapeutics Holdings, Inc |
| Short Percent Of Float | 0.104499996 |
| Short Ratio | 7.42 |
| Source Interval | 15 |
| State | CA |
| Symbol | RANI |
| Target High Price | 11.0 |
| Target Low Price | 5.0 |
| Target Mean Price | 7.4 |
| Target Median Price | 7.0 |
| Total Cash | 49,709,000 |
| Total Cash Per Share | 0.498 |
| Total Debt | 4,318,000 |
| Total Revenue | 1,633,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.45 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.084855 |
| Two Hundred Day Average Change | -0.102354944 |
| Two Hundred Day Average Change Percent | -0.09434897 |
| Type Disp | Equity |
| Volume | 1,035,598 |
| Website | https://www.ranitherapeutics.com |
| Zip | 95,131 |